BW
ABBV icon

Blalock Williams’s AbbVie ABBV Stock Holding History

Blalock Williams’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$254K Sell
1,170
-11
-0.9% -$2.44K 0.2% 111
2025
Q4 		$270K Sell
1,181
-40
-3% -$9.11K 0.22% 107
2025
Q3 		$283K Buy
+1,221
New +$249K 0.25% 96
2025
Q2 		– Sell
-986
Closed -$207K – 124
2025
Q1 		$207K Buy
+986
New +$192K 0.23% 109

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blalock Williams's ABBV Position: Q1 2026 in Review

Blalock Williams reduced its AbbVie (ABBV) stake by 0.93% in Q1 2026, selling an estimated $2.44K and leaving 1,170 shares worth $254K. The position accounts for 0.2% of the portfolio, ranked #111.

Blalock Williams first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $283K in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Blalock Williams held 1,170 shares of AbbVie worth $254K as of Q1 2026.
  • Blalock Williams sold 11 AbbVie shares in Q1 2026, an estimated $2.44K.
  • AbbVie made up 0.2% of Blalock Williams's portfolio in Q1 2026, its #111 holding.
  • Blalock Williams first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Blalock Williams's AbbVie position peaked at $283K in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Blalock Williams's 13F filing for Q1 2026, filed 14 May 2026.